NS2

· Aldeyra Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NS2, covering 2023-03-27 to 2023-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis [Phase 2]